Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 31
1972 34
1973 49
1974 63
1975 44
1976 79
1977 60
1978 79
1979 67
1980 75
1981 80
1982 53
1983 67
1984 79
1985 166
1986 174
1987 258
1988 337
1989 154
1990 215
1991 168
1992 183
1993 243
1994 151
1995 280
1996 182
1997 172
1998 158
1999 214
2000 167
2001 151
2002 164
2003 175
2004 179
2005 171
2006 189
2007 191
2008 171
2009 169
2010 152
2011 145
2012 162
2013 152
2014 167
2015 186
2016 167
2017 177
2018 184
2019 207
2020 200
2021 225
2022 177
2023 157
2024 53

Text availability

Article attribute

Article type

Publication date

Search Results

8,108 results

Results by year

Filters applied: . Clear all
Page 1
Androgenetic Alopecia: Therapy Update.
Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Devjani S, et al. Drugs. 2023 Jun;83(8):701-715. doi: 10.1007/s40265-023-01880-x. Epub 2023 May 11. Drugs. 2023. PMID: 37166619 Free PMC article. Review.
Acute Pancreatitis: Diagnosis and Treatment.
Szatmary P, Grammatikopoulos T, Cai W, Huang W, Mukherjee R, Halloran C, Beyer G, Sutton R. Szatmary P, et al. Drugs. 2022 Aug;82(12):1251-1276. doi: 10.1007/s40265-022-01766-4. Epub 2022 Sep 8. Drugs. 2022. PMID: 36074322 Free PMC article. Review.
Nirsevimab: First Approval.
Keam SJ. Keam SJ. Drugs. 2023 Feb;83(2):181-187. doi: 10.1007/s40265-022-01829-6. Drugs. 2023. PMID: 36577878 Review.
Tofersen: First Approval.
Blair HA. Blair HA. Drugs. 2023 Jul;83(11):1039-1043. doi: 10.1007/s40265-023-01904-6. Drugs. 2023. PMID: 37316681 Review.
Omaveloxolone: First Approval.
Lee A. Lee A. Drugs. 2023 Jun;83(8):725-729. doi: 10.1007/s40265-023-01874-9. Drugs. 2023. PMID: 37155124 Review.
Faricimab: First Approval.
Shirley M. Shirley M. Drugs. 2022 May;82(7):825-830. doi: 10.1007/s40265-022-01713-3. Drugs. 2022. PMID: 35474059 Review.
Efgartigimod: First Approval.
Heo YA. Heo YA. Drugs. 2022 Feb;82(3):341-348. doi: 10.1007/s40265-022-01678-3. Drugs. 2022. PMID: 35179720 Free PMC article. Review.
Teplizumab: First Approval.
Keam SJ. Keam SJ. Drugs. 2023 Apr;83(5):439-445. doi: 10.1007/s40265-023-01847-y. Drugs. 2023. PMID: 36877454 Review.
8,108 results